Navigation Links
CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System

ST. LOUIS, Aug. 29 /PRNewswire/ -- CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced that three sites have delivered clinical treatments utilizing Monaco(TM), its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.

Featuring biological modeling, constrained optimization, and Monte Carlo dose calculation algorithms, Monaco represents a fundamentally new approach to IMRT planning, including a unique and sophisticated set of tools to make the radiotherapy planning process easier, more straightforward and clinically reliable.

"The biologically-based Monaco IMRT treatment planning system produces clinically relevant plans, which are dosimetrically superior to plans from dose-based IMRT treatment planning systems, feature shorter plan delivery times, and can be easily verified with normal QA procedures," says Moyed Miften, Ph.D., DABR, and Allegheny General Hospital's Chief of Medical Physics. "The multi-criteria optimization and the sensitivity analysis tools in the Monaco system also help reduce the time needed to optimize IMRT plans."

While IMRT delivers significant improvements for radiation treatment, the technology presents challenges, including managing the time and resource intensive processes associated with planning. With Monaco, CMS offers new approaches that improve IMRT planning in the following ways:

-- Sensitivity Analysis tool that minimizes trial-and-error by guiding the decision making process

-- Smart Sequencing(TM), a constrained aperture optimization that produces efficient step-and-shoot segments

-- Biological models, voxel definition controls, and multi-criterial goals that provide more intuitive and direct control over the optimization process

Monaco was developed with the University of Tubingen in Germany. Markus Alber, Ph.D., and colleagues developed the Hyperion project, which is the engine behind the new Monaco system. CMS commercialized these innovative concepts and approaches from the Hyperion project to create the foundation for Monaco. The result is an advanced, clinically sophisticated IMRT planning system backed by the core research and capabilities of one of the world's leading research institutions.

About CMS

CMS, Inc., an Elekta Company, is a worldwide market leader in radiation treatment planning and workflow management, combining innovative software applications and advanced technology tools to deliver comprehensive treatment planning and workflow management solutions that integrate seamlessly in any clinical environment. With a commitment to product excellence and a reputation for world-class service and support, CMS makes all members of the treatment team more effective in providing patient care.

CMS is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.

With more than 2,500 employees globally, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at and

Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
2. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
3. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
4. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
5. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
6. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
7. Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
8. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
9. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
10. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
11. CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price
Post Your Comments:
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... ... Lizzie’s Lice Pickers just announced a special promotion that will run throughout ... of lice treatment product. In addition, customers will receive a complimentary head Check when ... is a sure way to ruin the holidays, so we encourage all of our ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
Breaking Medicine News(10 mins):